Clinical trials reimagined: Integrating community engagement and artificial intelligence.

Journal: Med (New York, N.Y.)
Published Date:

Abstract

In celebration of Clinical Trials Day, May 20, this collection of Voices highlights visionary perspectives on the evolving landscape of clinical research. It explores decentralized clinical trials, which bring research into participants' homes, enhancing diversity and convenience. It also emphasizes the imperative of community engagement to address health disparities and build trust. Finally, it showcases how generative AI promises to revolutionize drug discovery and clinical development through end-to-end automation and precision. Together, these insights underscore transformative shifts where innovation, inclusivity, and technology converge to accelerate the delivery of effective therapies for all.

Authors

  • Isla S Mackenzie
  • LaPrincess C Brewer
    Department of Cardiovascular Medicine (P.A.N., Z.I.A., L.C.B., S.N.H., X.Y., S.K., P.A.F., F.L.-J.), Mayo Clinic, Rochester, MN.
  • Alex Zhavoronkov
    Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA.